Literature DB >> 20955264

Preliminary study with bicalutamide in heterosexual and homosexual patients with prostate cancer: a possible implication of androgens in male homosexual arousal.

Ion G Motofei1, David L Rowland, Florian Popa, Drew Kreienkamp, Stana Paunica.   

Abstract

OBJECTIVE: • Not only has a precise characterization of libido and sexual arousal in men as a central neural process been lacking, but the interactive role of gonadal hormones and sexual orientation in such processes has never been investigated. We investigate the relationships among sexual hormones, sexual arousal, and sexual orientation in men by comparing the self-reported sexual response of heterosexual and homosexual men with locally advanced prostate neoplasm, receiving the non-steroidal anti-androgen bicalutamide as monotherapy. PATIENTS AND METHODS: • 29 Romanian men participated in this study: 17 heterosexual and 12 homosexual. Patients were undergoing treatment for prostate cancer consisting of a standard daily dose of 50 mg bicalutamide, a fast acting non-steroidal anti-androgen with action comparable to other anti-androgen drugs but with reportedly fewer sexual side effects. • Patients retrospectively provided information regarding their sexual functioning measured by the IIEF prior to commencing bicalutamide treatment. • Then, about five weeks later, patients were asked to prospectively provide information regarding their current sexual functioning while undergoing bicalutamide treatment.
RESULTS: • Overall IIEF scores as well as the Erectile Function, Orgasmic Function, Sexual Desire, and Overall Satisfaction subscales showed group, treatment, and group by treatment effects. • The Intercourse Satisfaction subscale showed group and group by treatment effects. • On most subscales, homosexual men showed lower functioning than heterosexual men, primarily in response to treatment with bicalutamide.
CONCLUSIONS: • Treatment with an anti-androgen in a clinical population of men undergoing therapy for prostate cancer affected homosexual men more than heterosexual men, although not all heterosexual men were unaffected. • These results are discussed in the context of dual sexual natures, a concept recently developed in the sexual literature. • Furthermore, these findings reiterate the importance of incorporating such variables as sexual orientation into studies investigating medical treatments on sexual response.
© 2010 THE AUTHORS. BJU INTERNATIONAL © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20955264     DOI: 10.1111/j.1464-410X.2010.09764.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  22 in total

1.  Fear of recurrence: the importance of self-efficacy and satisfaction with care in gay men with prostate cancer.

Authors:  Lindsey A Torbit; Jenna J Albiani; Cassandra J Crangle; David M Latini; Tae L Hart
Journal:  Psychooncology       Date:  2014-07-24       Impact factor: 3.894

Review 2.  Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations.

Authors:  Gwendolyn P Quinn; Julian A Sanchez; Steven K Sutton; Susan T Vadaparampil; Giang T Nguyen; B Lee Green; Peter A Kanetsky; Matthew B Schabath
Journal:  CA Cancer J Clin       Date:  2015-07-17       Impact factor: 508.702

3.  Health-related quality of life by human immunodeficiency virus status in a cross-sectional survey of gay and bisexual prostate cancer survivors.

Authors:  Elizabeth J Polter; Christopher W Wheldon; B R Simon Rosser; Nidhi Kohli; Benjamin D Capistrant; Aditya Kapoor; Badrinath Konety; Darryl Mitteldorf; Michael Ross; Kristine M C Talley; Loren Terveen; William West; Morgan M Wright
Journal:  Psychooncology       Date:  2019-11-11       Impact factor: 3.894

Review 4.  Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain.

Authors:  Ion G Motofei; David L Rowland; Mirela Manea; Simona R Georgescu; Ioana Păunică; Ioanel Sinescu
Journal:  Clin Drug Investig       Date:  2017-06       Impact factor: 2.859

5.  The effects of radical prostatectomy on gay and bisexual men's sexual functioning and behavior: qualitative results from the restore study.

Authors:  B R Simon Rosser; Benjamin Capistrant; Maria Beatriz Torres; Badrinath Konety; Enyinnaya Merengwa; Darryl Mitteldorf; William West
Journal:  Sex Relation Ther       Date:  2016-08-29

Review 6.  The effect of ethnicity and sexual preference on prostate-cancer-related quality of life.

Authors:  Nir Kleinmann; Nicholas G Zaorsky; Timothy N Showalter; Leonard G Gomella; Costas D Lallas; Edouard J Trabulsi
Journal:  Nat Rev Urol       Date:  2012-04-10       Impact factor: 14.432

7.  What Gay and Bisexual Men Treated for Prostate Cancer Want in a Sexual Rehabilitation Program: Results of the Restore Needs Assessment.

Authors:  B R Simon Rosser; Nidhi Kohli; Lindsey Lesher; Benjamin D Capistrant; James DeWitt; Gunna Kilian; Badrinath R Konety; Enyinnaya Merengwa; Darryl Mitteldorf; William West
Journal:  Urol Pract       Date:  2017-04-21

8.  Changes in sexual roles and quality of life for gay men after prostate cancer: challenges for sexual health providers.

Authors:  Tae L Hart; David W Coon; Marc A Kowalkowski; Karen Zhang; Justin I Hersom; Heather H Goltz; Daniela A Wittmann; David M Latini
Journal:  J Sex Med       Date:  2014-05-30       Impact factor: 3.802

Review 9.  Cancer in Sexual and Gender Minority Patients: Are We Addressing Their Needs?

Authors:  Elizabeth J Cathcart-Rake
Journal:  Curr Oncol Rep       Date:  2018-09-13       Impact factor: 5.075

10.  Understanding Prostate Cancer in Gay, Bisexual, and Other Men Who Have Sex with Men and Transgender Women: A Review of the Literature.

Authors:  B R Simon Rosser; Shanda L Hunt; Benjamin D Capistrant; Nidhi Kohli; Badrinath R Konety; Darryl Mitteldorf; Michael W Ross; Kristine M Talley; William West
Journal:  Curr Sex Health Rep       Date:  2019-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.